Showing 126–150 of 200 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Kwara A, Yang H, Antwi S, Enimil A, Gillani FS, et al.
… participants, 43 (41.0%) had TB coinfection. Children with TB/HIV coinfection compared to those with HIV infection were younger, had lower median weight-for-age Z score, and received a higher median efavirenz weight-adjusted dose. Geometric mean (GM) efavirenz peak concentration…
Ogyiri L, Lartey M, Ojewale O, Adjei AA, Kwara A, et al.
…cy Virus (HIV) globally. Ghana as one of the 30 high burden TB/HIV countries has a high annual TB case-fatality rate of 10%. The study sought to assess the effect of HIV infection on TB treatment outcomes and assess the time to mortality after treatment onset. Methods We conducte…
Gemechu LL, Debusho LK
An in-depth analysis of the epidemiological patterns of TB/HIV co-infection is essential since it helps to target high-risk areas with effective control measures. The main objective of this study was to assess the spatial clustering of TB/HIV co-infection prevalence in Ethiopia f…
Pourakbari B, Mamishi S, Banar M, Keshtkar AA, Mahmoudi S
…lthough several studies have investigated the prevalence of TB/HIV co-infection in Iran, the results are inconsistent. The current systematic review and meta-analysis was planned to estimate the overall prevalence of TB/HIV co-infection in Iran. Methods Electronic databases, incl…
Maseko TG, Rambaran S, Ngubane S, Lewis L, Ngcapu S, et al.
…sease severity measured by the presence of lung cavitation. TB/HIV co-infection led to the expansion of functionally impaired CD56 neg NK cell subset. TB treatment completion resulted in restoration of total NK cells, NK cell subset redistribution and downregulation of several NK…
Yang J, Zheng X, Zhang S, Wang H
…rovide a reference for clinical screening and prevention of TB/HIV dual infection. TB patients and HIV-infected/AIDS patients registered in Fuzhou Center for Disease Control and Prevention were selected as research subjects. The population characteristics of TB/HIV dual infection…
Hong BL, D'Cunha R, Li P, Al-Shaer MH, Alghamdi WA, et al.
…alized C max and AUC between adults with TB and adults with TB/HIV; however, the AUC in pediatric patients was significantly different between patients with TB and patients with TB/HIV. In addition, no significance was observed comparing the dose-normalized C max and AUC of pedia…
Sama LF, Sadjeu S, Tchouangueu TF, Dabou S, Kuh GF, et al.
…g the period of study. Outcome Measures . The prevalence of TB/HIV and TB/HIV/DM, signs and symptoms, imaging results, and bacteriology status among TB/HIV, TB/HIV/DM coinfected, and comorbidity cases. Results Of 1115 participants, 38.57% had TB/HIV, and 5.83% had TB/HIV/DM. Amon…
Banda L, Oladimeji O
…haran Africa presents significant public health challenges. TB/HIV comorbidity is influenced by various social determinants, including social, economic, cultural, and environmental factors, impacting disease transmission risk, accurate diagnosis, and treatment outcomes. This stud…
Kadia BM, Aroke D, Njefi KP, Tochie JN, Tianyi FL, et al.
…me countries (LMICs), the potential of programs integrating TB/HIV treatment to sustain favourable MDR-TB treatment outcomes is poorly elucidated. The objective of this review is to perform a systematic collection, critical appraisal and synthesis of existing evidence on therapeu…
Omara G, Bwayo D, Mukunya D, Nantale R, Okia D, et al.
TB/HIV co-infection is associated with poorer treatment outcomes compared to TB alone. This study assessed the TB treatment success rate and its predictors among TB/HIV co-infected patients in East and North Eastern Uganda. A retrospective cohort design was used, involving 324 pa…
Azeez A, Mutambayi R, Odeyemi A, Ndege J
…ective cohort conducted to compare the survivorship between TB/HIV patients for 8 months DOTS. Death among TB patients was considered as failures and those defaulted or survived were censored. The Cox proportional-hazards regression and log-linear model were used to establish the…
Müller P, Velez Lapão L
…larities and differences of barriers identified across high TB/HIV burden countries. A secondary objective was to identify facilitators for implementing both preventive therapies. Methods We searched MEDLINE, Web of Science and SCOPUS databases for peer-reviewed literature publis…
Fenta A, Demeke G, Bitew A, Kebede D, Hailu T
…was done using SPSS version 20.0. Results The prevalence of TB/HIV co-infection was 18.1%. TB/HIV patients whose drunk alcohol (AOR=2.36, 95% CI=1.07-5.19), BMI Conclusion The prevalence of TB among HIV sero-positive individuals is high. Determinant factors, including drinking al…
Matji R, Maama L, Roscigno G, Lerotholi M, Agonafir M, et al.
…o of prevalence to case notification was estimated at 1.22. TB/HIV coinfection was identified in 39 (29.6%) participants. Out of the 1,825 participants who reported a cough, 50% of these participants, mostly men, did not seek care. Those who sought care predominantly went to the …
Kiplimo R, Kosgei M, Mwangi A, Onyango E, Ogero M, et al.
…eatment constituted 6.38% (event: 15.25%; no event: 5.29%). TB/HIV co-infection was at 31.23% (event: 47.87%; no event: 29.20%). The association parameter 1.03 (CI[1.03,1.04]) was found to be positive and significantly different from zero, interpreted as follows: The estimate of …
Shah NS, Kityo C, Hughes MD, McCarthy C, Wallis CL, et al.
…d of TB treatment. Results We enrolled 91 participants with TB/HIV: 75 (82%) ART-naive participants starting TLD after a median 15 days on TB treatment, 10 (11%) ART-naive participants starting TLD and TB treatment, 5 (5%) starting TB treatment after a median 3.3 years on TLD, an…
Sampson Antwi, Anthony Enimil, Hongmei Yang, Charles Martyn-Dickens, Albert Dompreh, et al.
… on rifampin-containing TB treatment. **METHODS:** AWH and TB/HIV coinfection on TB treatment receiving tenofovir (TFV) disoproxil fumarate (TDF) 300 mg/lamivudine (3TC) 300 mg or emtricitabine (FTC) 200 mg daily for at least 8 weeks were enrolled. DBS were …
Mera HB, Wagnew F, Akelew Y, Hibstu Z, Berihun S, et al.
…72%) followed by Zambia (11.68%) and then Ethiopia (9.22%). TB/HIV coinfection (OR 4.99 (95% CI: 2.60-9.58)), Body mass index (BMI Conclusion The prevalence of pulmonary TB among SSA prison inmates was found to be high as compared to total population. TB/HIV coinfection, BMI, inc…
Bohlbro AS, Mendes AM, Sifna A, Gomes V, Rudolf F, et al.
…ver the period from 294 per 100,000 in 2004 to 273 in 2020. TB/HIV coinfection declined from 108 in 2004 to 14 in 2020, as did incidence among females and smear-negative cases. Conclusions Incidence of PTB in Bissau, Guinea-Bissau is declining slowly, if at all. TB incidence amon…
Saadick Mugerwa Ssentongo, Kenneth Kwenya, Bonniface Oryokot, Ronald Opito, Susan Alwedo, et al.
…sful treatment rate. There is a need to scale up integrated TB/HIV differentiated services, ensure Viral load suppression through adherence support for the TB/HIV coinfected clients, and increase Tb awareness to achieve the end TB Strategy by 2030.
Ellen Samwiri Nkambule, Michael E Herce, Balwani Chingatichifwe Mbakaya
…hree-stage model of HIV/TB care to guide the improvement of TB/HIV service delivery in select Malawian prisons. **DESIGN:** We conducted a pilot implementation research study using multimethods from May 2022 to April 2023. **SETTING:** Two semi-urban prisons in Malawi. **PARTI…
Nicole F Maranchick, Charles Martyn-Dickens, Anthony Enimil, Hongmei Yang, Aikins Kofi Amissah, et al.
…blished values in adults. A total of 85 children (41 TB, 44 TB/HIV) were included. The median (range) age was 5 years (0.3-14.5), and 61.2% were male. Median (range) doses for PZA and EMB were 31.6 (21.4-49.7) and 21.4 mg/kg (14.3-34.2), respectively. PZA was best described using…
Izudi J, Okello G, Bajunirwe F
…t regimen is suboptimal. TSR is less likely for people with TB/HIV co-infection or unknown HIV serostatus, high MTB sputum smear load, and on digital community-based DOTs. We recommend strengthening of TB/HIV collaborative activities and people with TB with high MTB sputum smear …
Ambaye GY, Tsegaye GW
…n Age between 26-45 years old, previously treated cases and TB/HIV co-infection were identified as the determinants of MDR-TB. Special attention should be given to age between 26-45 years old, previous history of TB treatment and TB/HIV co-infection to prevent and control MDR-TB …